Kaye Edward M. MD bought CYTK

July 15, 2025 · Form 4 insider transaction

Kaye Edward M. MD bought 328 shares of Cytokinetics, Incorporated at $38.01 per share, a transaction worth $12.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction

Acquired (buy-side)

328

Price

$38.01

Total value

$12.5K

InsiderKaye Edward M. MD

RoleDirector

CompanyCytokinetics, Incorporated (CYTK)

SecurityCommon Stock

Transaction codeA: Grant or award

Transaction dateJuly 15, 2025

Filing dateJuly 16, 2025

Shares owned after29,986

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Director equity in lieu of cash retainer program.

View the original Form 4 on SEC EDGAR